D8 (RBOT)
(Real Time Quote from BATS)
$8.88 USD
0.00 (0.00%)
Updated Aug 7, 2025 10:44 AM ET
4-Sell of 5 4
F Value C Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
RBOT 8.88 0.00(0.00%)
Will RBOT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RBOT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RBOT
What Makes D8 (RBOT) a New Buy Stock
Vicarious Surgical (RBOT) Partners LSU Health New Orleans
RBOT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for RBOT
Vicarious Surgical (RBOT) Names Stephen From as New CEO
Vicarious Surgical Announces Leadership Transition: Stephen From, Healthcare Industry Veteran, ...
Vicarious Surgical appoints new CEO; co-founder Adam Sachs to remain as president
Vicarious Surgical names Stephen From CEO
Vicarious Surgical to Report Second Quarter 2025 Financial Results on August 12, 2025 | RBOT ...